| Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study S Flasche, AJ Van Hoek, E Sheasby, P Waight, N Andrews, C Sheppard, ... PLoS medicine 8 (4), e1001017, 2011 | 327 | 2011 |
| The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England AJ Van Hoek, N Andrews, PA Waight, J Stowe, P Gates, R George, ... Journal of Infection 65 (1), 17-24, 2012 | 287 | 2012 |
| The burden of influenza in England by age and clinical risk group: a statistical analysis to inform vaccine policy D Cromer, AJ Van Hoek, M Jit, WJ Edmunds, D Fleming, E Miller Journal of Infection 68 (4), 363-371, 2014 | 282 | 2014 |
| Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England AJ Van Hoek, CL Sheppard, NJ Andrews, PA Waight, MPE Slack, ... Vaccine 32 (34), 4349-4355, 2014 | 220 | 2014 |
| Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation M Baguelin, AJ Van Hoek, M Jit, S Flasche, PJ White, WJ Edmunds Vaccine 28 (12), 2370-2384, 2010 | 215 | 2010 |
| Assessing vaccine hesitancy in the UK population using a generalized vaccine hesitancy survey instrument J Luyten, L Bruyneel, AJ Van Hoek Vaccine 37 (18), 2494-2501, 2019 | 211 | 2019 |
| Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales AJ Van Hoek, N Gay, A Melegaro, W Opstelten, WJ Edmunds Vaccine 27 (9), 1454-1467, 2009 | 180 | 2009 |
| Effect of serotype on focus and mortality of invasive pneumococcal disease: coverage of different vaccines and insight into non-vaccine serotypes AJ Van Hoek, N Andrews, PA Waight, R George, E Miller PloS one 7 (7), e39150, 2012 | 152 | 2012 |
| Cost effectiveness of pneumococcal vaccination among Dutch infants: economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 … MH Rozenbaum, EAM Sanders, AJ van Hoek, AGSC Jansen, ... Bmj 340, 2010 | 147 | 2010 |
| The impact of pandemic influenza H1N1 on health-related quality of life: a prospective population-based study AJ van Hoek, A Underwood, M Jit, E Miller, WJ Edmunds PloS one 6 (3), e17030, 2011 | 128 | 2011 |
| Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England AJ Van Hoek, A Melegaro, E Zagheni, WJ Edmunds, N Gay Vaccine 29 (13), 2411-2420, 2011 | 127 | 2011 |
| Pneumococcal carriage in children and their household contacts six years after introduction of the 13-valent pneumococcal conjugate vaccine in England J Southern, N Andrews, P Sandu, CL Sheppard, PA Waight, NK Fry, ... PLoS One 13 (5), e0195799, 2018 | 126 | 2018 |
| Lower vaccine uptake amongst older individuals living alone: A systematic review and meta-analysis of social determinants of vaccine uptake A Jain, AJ Van Hoek, D Boccia, SL Thomas Vaccine 35 (18), 2315-2328, 2017 | 120 | 2017 |
| The early transmission dynamics of H1N1pdm influenza in the United Kingdom A Ghani, M Baguelin, J Griffin, S Flasche, AJ Van Hoek, S Cauchemez, ... PLoS currents 1, RRN1130, 2010 | 117 | 2010 |
| Burden of paediatric respiratory syncytial virus disease and potential effect of different immunisation strategies: a modelling and cost-effectiveness analysis for England D Cromer, AJ Van Hoek, AT Newall, AJ Pollard, M Jit The lancet Public health 2 (8), e367-e374, 2017 | 104 | 2017 |
| Elucidating the impact of the pneumococcal conjugate vaccine programme on pneumonia, sepsis and otitis media hospital admissions in England using a composite control D Thorrington, N Andrews, J Stowe, E Miller, AJ Van Hoek BMC medicine 16, 1-14, 2018 | 96 | 2018 |
| Vaccine effectiveness against SARS-CoV-2 transmission and infections among household and other close contacts of confirmed cases, the Netherlands, February to May 2021 B de Gier, S Andeweg, R Joosten, R Ter Schegget, N Smorenburg, ... Eurosurveillance 26 (31), 2100640, 2021 | 93 | 2021 |
| The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom AJ Van Hoek, A Melegaro, N Gay, J Bilcke, WJ Edmunds Vaccine 30 (6), 1225-1234, 2012 | 92 | 2012 |
| Modelling the impact of local reactive school closures on critical care provision during an influenza pandemic T House, M Baguelin, AJ Van Hoek, PJ White, Z Sadique, K Eames, ... Proceedings of the Royal Society B: Biological Sciences 278 (1719), 2753-2760, 2011 | 88 | 2011 |
| Vaccination of risk groups in England using the 13 valent pneumococcal conjugate vaccine: economic analysis MH Rozenbaum, AJ Van Hoek, D Fleming, CL Trotter, E Miller, ... Bmj 345, 2012 | 86 | 2012 |
John EdmundsProfessor of Infectious Disease Modelling, London School of Hygiene and Tropical MedicineZweryfikowany adres z lshtm.ac.uk